|75.80||+2.71 / +3.71%|
As of 4:02pm ET
|75.80||0.00 / 0.00%|
The 5 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 157.00, with a high estimate of 285.00 and a low estimate of 94.00. The median estimate represents a +107.12% increase from the last price of 75.80.
The current consensus among 6 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.